1. Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC). Issue 9 (30th October 2018) Authors: Teo, Min; Scher, Howard Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗